Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (991-1000 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemiaCarolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Mabs|March 7, 2014
Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28Nicolas Poirier, Caroline Mary, Stephanie Le Bas-Bernardet, et al.
Mabs|August 30, 2022
Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapyFang Xie, Luchen Zhang, Sanyuan Shi, et al.
Mabs|July 24, 2012
Trifunctional antibody ertumaxomab: Non-immunological effects on Her2 receptor activity and downstream signalingSimone Diermeier-Daucher, Olaf Ortmann, Stefan Buchholz, et al.
Mabs|September 26, 2012
IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CAJohn Marquardt, Richard H J Begent, Kerry Chester, et al.
Mabs|September 26, 2012
Characterization of a variety of neutralizing anti-heparin-binding epidermal growth factor-like growth factor monoclonal antibodies by different immunization methodsIsamu Tsuji, Shuji Sato, Kentaro Otake, et al.
Mabs|September 29, 2012
Identification of a single base-pair mutation of TAA (Stop codon) → GAA (Glu) that causes light chain extension in a CHO cell derived IgG1Taylor Zhang, Yungfu Huang, Scott Chamberlain, et al.
Mabs|October 4, 2012
Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor siteThomas List, Dario Neri
Mabs|August 29, 2012
Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodiesChristian Klein, Claudio Sustmann, Markus Thomas, et al.
Mabs|August 29, 2012
Tailored amino acid diversity for the evolution of antibody affinityAndrea González-Muñoz, Evert Bokma, Desmond O'Shea, et al.
Pageof 184

Showing results (991-1000 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemiaCarolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Mabs|March 7, 2014
Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28Nicolas Poirier, Caroline Mary, Stephanie Le Bas-Bernardet, et al.
Mabs|August 30, 2022
Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapyFang Xie, Luchen Zhang, Sanyuan Shi, et al.
Mabs|July 24, 2012
Trifunctional antibody ertumaxomab: Non-immunological effects on Her2 receptor activity and downstream signalingSimone Diermeier-Daucher, Olaf Ortmann, Stefan Buchholz, et al.
Mabs|September 26, 2012
IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CAJohn Marquardt, Richard H J Begent, Kerry Chester, et al.
Mabs|September 26, 2012
Characterization of a variety of neutralizing anti-heparin-binding epidermal growth factor-like growth factor monoclonal antibodies by different immunization methodsIsamu Tsuji, Shuji Sato, Kentaro Otake, et al.
Mabs|September 29, 2012
Identification of a single base-pair mutation of TAA (Stop codon) → GAA (Glu) that causes light chain extension in a CHO cell derived IgG1Taylor Zhang, Yungfu Huang, Scott Chamberlain, et al.
Mabs|October 4, 2012
Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor siteThomas List, Dario Neri
Mabs|August 29, 2012
Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodiesChristian Klein, Claudio Sustmann, Markus Thomas, et al.
Mabs|August 29, 2012
Tailored amino acid diversity for the evolution of antibody affinityAndrea González-Muñoz, Evert Bokma, Desmond O'Shea, et al.
Pageof 184